![Case report: Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing Case report: Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing](https://scx2.b-cdn.net/gfx/news/hires/2023/exploring-the-potentia.jpg)
Case report: Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing
![PDF) ESMO Clinical Practice Guidelines Ovarian Cancer Clinical Case Presentation | madhu mitha - Academia.edu PDF) ESMO Clinical Practice Guidelines Ovarian Cancer Clinical Case Presentation | madhu mitha - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/57727663/mini_magick20190110-25306-do96ji.png?1547140276)
PDF) ESMO Clinical Practice Guidelines Ovarian Cancer Clinical Case Presentation | madhu mitha - Academia.edu
![Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports | Anticancer Research Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/9/5263/F1.large.jpg)
Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports | Anticancer Research
![Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary care | British Journal of General Practice Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary care | British Journal of General Practice](https://bjgp.org/content/bjgp/68/676/e750/F1.large.jpg)
Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary care | British Journal of General Practice
![Frontiers | Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature Frontiers | Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature](https://www.frontiersin.org/files/Articles/873198/fonc-12-873198-HTML/image_m/fonc-12-873198-g001.jpg)
Frontiers | Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature
![A rare case of ovarian adenomyoma mimicking primary invasive ovarian cancer with a contralateral serous borderline ovarian tumor: A case report and review of the literature - ScienceDirect A rare case of ovarian adenomyoma mimicking primary invasive ovarian cancer with a contralateral serous borderline ovarian tumor: A case report and review of the literature - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2405844020312500-mmc1.jpg)
A rare case of ovarian adenomyoma mimicking primary invasive ovarian cancer with a contralateral serous borderline ovarian tumor: A case report and review of the literature - ScienceDirect
![Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial - The Lancet Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/3f11f382-9fb5-4a21-b9eb-8db68bf68f29/gr1.gif)
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial - The Lancet
![Clinical case study meets population cohort: identification of a BRCA1 pathogenic founder variant in Orcadians | European Journal of Human Genetics Clinical case study meets population cohort: identification of a BRCA1 pathogenic founder variant in Orcadians | European Journal of Human Genetics](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41431-023-01297-w/MediaObjects/41431_2023_1297_Fig1_HTML.png)
Clinical case study meets population cohort: identification of a BRCA1 pathogenic founder variant in Orcadians | European Journal of Human Genetics
![A clinical case of successful treatment of a giant serous endometrial carcinoma imitating ovarian cancer - Berishvili - Journal of Clinical Practice A clinical case of successful treatment of a giant serous endometrial carcinoma imitating ovarian cancer - Berishvili - Journal of Clinical Practice](https://journals.eco-vector.com/public/journals/19/cover_issue_3857_en_US.jpg)
A clinical case of successful treatment of a giant serous endometrial carcinoma imitating ovarian cancer - Berishvili - Journal of Clinical Practice
![Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation | Scientific Reports Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-83276-z/MediaObjects/41598_2021_83276_Fig1_HTML.jpg)